Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,899,630
+$397,645 QoQ
Shares Held
7,549
+9.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2,005
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Point Capital Partners LLC holds $5,958,387 across 7 Drug Manufacturers - General names. ABBV ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
7,549 | $1,899,630 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,670 | $985,595 | |
| 3 | AMGN |
Amgen Inc
|
2,701 | $978,086 | |
| 4 | JNJ |
Johnson & Johnson
|
3,548 | $901,085 | |
| 5 | LLY |
ELI LILLY & Co
|
343 | $411,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,249 | $410,478 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,458 | $372,109 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,899,630 | 7,549 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,501,985 | 6,906 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,313,817 | 5,750 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,335,754 | 5,769 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,229,918 | 6,626 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,339,880 | 6,395 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,262,025 | 7,102 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,163,354 | 5,891 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $897,392 | 5,232 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $945,099 | 5,190 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $805,844 | 5,200 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $944,742 | 6,338 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $890,430 | 6,609 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,156,866 | 7,259 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $942,671 | 5,833 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $872,230 | 6,499 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $998,603 | 6,520 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,079,166 | 6,657 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $781,799 | 5,774 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $623,380 | 5,779 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $386,918 | 3,435 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $360,913 | 3,335 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $356,488 | 3,327 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $291,411 | 3,327 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $7,101,752 | 72,334 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,497,641 | 72,157 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||